Ping Wu

Development of GuaB Inhibitors to Treat Mycobacterium tuberculosis Infection

Abstract Mycobacterium tuberculosis (Mtb) is responsible for more deaths per year than any other infectious disease. Resistance of circulating Mtb to the standard of care treatment regimen is an urgent global health crisis for which novel antibiotic treatments are needed. We have...